Jefferies Initiates Coverage On Penumbra with Buy Rating, Announces Price Target of $230
Jefferies analyst Matthew Taylor initiates coverage on Penumbra (NYSE:PEN) with a Buy rating and announces Price Target of $230.
Analyst Ratings for Penumbra
Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter:
Penumbra Ramps Up Efforts To Launch Indigo Aspiration System In Japan
Penumbra Inc (NYSE:PEN) and Japan-based medical device manufacturer Asahi Intecc Co will collaborate to introduce Penumbra’s Indigo Aspiration System into the Japanese market…
Susquehanna Slashes Price Target On NetApp, Plus Compass Point Boosts PT On This Stock By 75%
Susquehanna cut the price target on NetApp, Inc. (NASDAQ: NTAP) from $100 to $75. Susquehanna analyst Mehdi Hosseini also downgraded the stock from Positive to Neutral. NetApp shares fell 1.3% to trade at $67.76 on Monday.
BTIG Maintains Buy on Penumbra, Raises Price Target to $239
BTIG analyst Ryan Zimmerman maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $213 to $239.
Truist Securities Maintains Buy on Penumbra, Raises Price Target to $230
Truist Securities analyst David Rescott maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $180 to $230.
Citing ‘Lightning Fast Growth,’ Needham Upgrades This Vascular Device Company
Needham upgraded Penumbra Inc (NYSE:PEN) to Buy from Hold, with a price target of $244. The analyst notes that management indicated…
Expert Ratings for Penumbra
Within the last quarter, Penumbra (NYSE:PEN) has observed the following analyst ratings:
What 5 Analyst Ratings Have To Say About Penumbra
Over the past 3 months, 5 analysts have published their opinion on Penumbra (NYSE:PEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
